This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Feb 9;359(9305):458-9.

doi: 10.1016/S0140-6736(02)07671-7.

Resistance to targeted therapy in leukaemia

James D Griffin¹

Affiliations

PMID: 11853786
DOI: 10.1016/S0140-6736(02)07671-7

Comment

Resistance to targeted therapy in leukaemia

James D Griffin. Lancet. 2002.

. 2002 Feb 9;359(9305):458-9.

doi: 10.1016/S0140-6736(02)07671-7.

Author

James D Griffin¹

Affiliation

¹ Leukemia Program, Dana-Farber Cancer Institute, Boston, MA 02115, USA. james_griffin@dfci.harvard.edu

PMID: 11853786
DOI: 10.1016/S0140-6736(02)07671-7

No abstract available

PubMed Disclaimer

Comment in

Decrease of resistance to imatinib in leukaemia.
Bakalova R, Zhelev Z, Ohba H. Bakalova R, et al. Lancet. 2002 May 18;359(9319):1776-7. doi: 10.1016/s0140-6736(02)08622-1. Lancet. 2002. PMID: 12049890 No abstract available.
Decrease of resistance to imatinib in leukaemia.
Gambacorti-Passerini C. Gambacorti-Passerini C. Lancet. 2002 May 18;359(9319):1777. doi: 10.1016/S0140-6736(02)08623-3. Lancet. 2002. PMID: 12049891 No abstract available.

Comment on

Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study.
Hofmann WK, de Vos S, Elashoff D, Gschaidmeier H, Hoelzer D, Koeffler HP, Ottmann OG. Hofmann WK, et al. Lancet. 2002 Feb 9;359(9305):481-6. doi: 10.1016/S0140-6736(02)07678-X. Lancet. 2002. PMID: 11853794
BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study.
von Bubnoff N, Schneller F, Peschel C, Duyster J. von Bubnoff N, et al. Lancet. 2002 Feb 9;359(9305):487-91. doi: 10.1016/S0140-6736(02)07679-1. Lancet. 2002. PMID: 11853795

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information